Coughlin Christopher J
- SEC CIK
- 0001110750
No open-market purchases or sales filed in the past year.
Current role at each company
- CNC Centene CorpDirectoras of Jul 1, 2026
- KRTX Karuna Therapeutics, Inc.Directoras of Mar 18, 2024
- PBH Prestige Consumer Healthcare Inc.Directoras of Aug 3, 2022
- ALXN Alexion Pharmaceuticals, Inc.Directoras of Jul 23, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Coughlin Christopher J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CNC Centene Corp
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2024 (view filing) | Dec 16 | 1 day | Coughlin Christopher JDirector | PPurchase | +10.0K | $59.44 | +$594.4K | +37.9%36.4K after | |
| May 24, 2024 (view filing) | May 14 | 10 daysLate | Coughlin Christopher JDirector | SSale | −878 | $76.75 | −$67.4K | −100.0%0 after | |
| May 3, 2022 (view filing) | Apr 29 | 4 days | Coughlin Christopher JDirector | PPurchase | +12.0K | $81.37 | +$976.4K | +310.5%15.9K after |